Reuters reported on January 20 that Britain’s GSK and Japan’s Shionogi said Pfizer Inc. (NYSE:PFE) will exit their ...

Pfizer is also making strides in the weight management market. It now owns one of the more promising mid-stage assets in this ...

CNBC spoke to executives from Eli Lilly, Novo Nordisk, Pfizer and other drugmakers at the annual JPMorgan Healthcare Conference in San Francisco.

Pfizer’s stake in ViiV Healthcare will be taken over by Shiongi, another minority shareholder in the HIV medicines company.

The healthcare giant has had trouble winning over investors in the past year despite an incredibly low valuation.

In recent decades, merger and acquisition activity has sent long-standing Michigan businesses' leadership out-of-state and even the country.

Maryland-based Novavax signed a licensing agreement allowing Pfizer access to its technology that boosts immune responses to ...

In 2025's third quarter, multiple large vaccine developers, including Pfizer and GSK, saw vaccine sales tick up globally ...

Novavax’s Pfizer Matrix-M licensing deal brings $30M upfront, milestones & royalties. Read the full analysis here.

Buying into it will quickly have you invested in 100 companies with at least 10 years of dividend increases. Top holdings ...

Novavax said on Tuesday it signed a licensing ​agreement allowing Pfizer access to its technology that boosts immune ...

Novavax Inc. (NASDAQ:NVAX) shares are up 3.3% to trade at $8.27 at last glance, after the vaccine company singed a licensing ...